![](/img/cover-not-exists.png)
SAT0307 Lesinurad Monotherapy in Gout Patients Intolerant to Xanthine Oxidase Inhibitors (Light): A Randomized, Double-Blind, Placebo-Controlled, 6-Month Phase III Clinical Trial
Tausche, A.-K., Alten, R., Dalbeth, N., Kopicko, J., Bhakta, N., Storgard, C., Baumgartner, S., Saag, K.Volume:
74
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2015-eular.2090
Date:
June, 2015
File:
PDF, 84 KB
english, 2015